Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study

Katerina Vrzalikova; Joseph Skarda; Jiri Ehrmann; Paul G. Murray; Eduard Fridman; Jury Kopolovic; Petra Knizetova; Marian Hajduch; Jiri Klein; Vitezslav Kolek

首页> 外文期刊>Journal of Cancer Research and Clinical Oncology >Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study

【24h】

Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study

机译：Bmi-1癌蛋白表达在非小细胞肺癌患者中的预后价值：组织芯片研究

获取原文

获取原文并翻译 | 示例

获取外文期刊封面封底 >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Purpose Bmi-1 is a Polycomb group member which participates in many physiological processes as well as in a wide spectrum of cancers. The aim of this study was to investigate Bmi-1 expression in non-small cell lung cancer (NSCLC) in respect to clinicopathological features and therapeutic outcomes.

机译：目的Bmi-1是一个Polycomb小组成员，它参与许多生理过程以及广泛的癌症。这项研究的目的是研究Bmi-1在非小细胞肺癌（NSCLC）中的临床病理特征和治疗效果。

著录项

来源
《Journal of Cancer Research and Clinical Oncology》 |2008年第9期|p.1037-1042|共6页
作者
Katerina Vrzalikova; Joseph Skarda; Jiri Ehrmann; Paul G. Murray; Eduard Fridman; Jury Kopolovic; Petra Knizetova; Marian Hajduch; Jiri Klein; Vitezslav Kolek;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类
关键词
Tissue microarray; Non; small cell lung cancer; Bmi; 1 oncogene; Polycomb genes;

机译：组织芯片;非小细胞肺癌Bmi;1癌基因;聚梳基因;

相似文献

外文文献
中文文献
专利

1. Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study. [J] . Vrzalikova K, Skarda J, Ehrmann J, Journal of Cancer Research and Clinical Oncology . 2008,第9期

机译：Bmi-1癌蛋白表达在非小细胞肺癌患者中的预后价值：一项组织芯片研究。
2. Prognostic value of Bmi-1 oncoprotein expression in non-small cell lung cancer [J] . Dan Xiong, Yunlin Ye, Bohua Kuang, Frontiers in Laboratory Medicine . 2018,第3期

机译：Bmi-1癌蛋白表达在非小细胞肺癌中的预后价值
3. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: A retrospective clinicopathological study of 948 cases using tissue microarrays [J] . ZimpferA., MaruschkeM., RehnS., BJU international . 2014,第2期

机译：肾肿瘤中上皮细胞粘附/激活分子（EpCAM）表达的预后和诊断意义：使用组织芯片对948例病例的回顾性临床病理研究
4. Metabolomics of eye fluids from retinoblastoma patients and its correlation to tissue gene expression studies [C] . Syed Salman Lateef, Sudha Rajagopalan, Seetaramanjaneyulu Gundimeda, ASMS Conference on Mass Spectrometry and Allied Topics . 2015

机译：视网膜母细胞瘤患者的眼液代谢组织及其与组织基因表达研究的相关性
5. Identification of differentially expressed genes in HPV-associated cancers using gene expression, tissue, and microRNA microarrays. [D] . Martinez, Ivan. 2007

机译：使用基因表达，组织和微RNA芯片鉴定HPV相关癌症中差异表达的基因。
6. Prognostic Implication of SOX2 Expression Associated with p16 in Oropharyngeal Cancer: A Study of Consecutive Tissue Microarrays and TCGA [O] . Jungirl Seok, Chang Hwan Ryu, Junsun Ryu, 2020

机译：对口咽癌P16相关联的SOx2表达的预后意义：连续组织微阵列和TCGA的研究
7. Corrigendum A serum microRNA signature as a prognostic factor for patients with advanced NSCLC and its association with tissue microRNA expression profiles [O] . Jing Guo, Rui Meng, Zhongyuan Yin, 2021

机译：静脉血清microRNA签名作为高级NSCLC患者的预后因素及其与组织MicroRNA表达谱的关系

Prognostic value of Bmi-1 oncoprotein expression in NSCLC patients: a tissue microarray study

摘要

著录项

相似文献

相关主题

期刊订阅